Publications by authors named "Ihtisham Habib"
Colchicine, a long-established anti-inflammatory medication, has emerged as a potential therapeutic agent for secondary prevention of stroke. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of colchicine in preventing secondary stroke by comprehensively synthesizing available evidence. A systematic literature search was conducted across multiple electronic databases from inception to November 15, 2024, using comprehensive search strategies.
View Article and Find Full Text PDFLipoprotein(a) (Lp(a)) has emerged as a significant cardiovascular risk factor, particularly in patients with ischemic heart disease (IHD). This systematic review and meta-analysis aimed to synthesize evidence on the impact of Lp(a) levels on cardiovascular outcomes in IHD patients. A comprehensive literature search was conducted across multiple databases, covering publications from January 2016 to October 2024.
View Article and Find Full Text PDFArticle Synopsis
- Atrial fibrillation (AF) patients with liver disease face challenges in anticoagulation management due to their higher risks for both blood clots and bleeding.
- This study compared the effectiveness and safety of direct oral anticoagulants (DOACs)—apixaban, rivaroxaban, and dabigatran—against vitamin K antagonists (VKAs), finding that all DOACs were superior, particularly apixaban, in preventing strokes and bleeding events.
- While promising, the research is limited by the mostly observational studies included, indicating the need for more large-scale trials to determine the best dosing and management strategies for these patients.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder with diverse clinical manifestations. Among these, ocular complications are notably prevalent, affecting up to one-third of patients. One rare but serious ocular complication of SLE is central retinal artery occlusion (CRAO), which can result in significant vision loss.
View Article and Find Full Text PDF